의료진프로필

Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities

Lee, TH; Kim, K; Oh, D; Yang, K; Jeong, HS; Chung, MK; Ahn, YC

Search for practical scaling factors of Bragg peak arrangement for line-scanning proton beam therapy in RayStation

Chung, K; Kim, N; Cho, WK; Kim, H; Oh, D; Park, W; Park, HC; Lim, D

Topography and probability diagram of cervical and intra-parotid lymph node metastasis in parotid gland cancer

Choi, N; Kang, YJ; Cho, J; Oh, D; Jeong, J; Jeong, HS

Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinoma

Park, SY; Lee, JH; Oh, D; Sun, JM; Yun, JH; Jeon, YJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Kim, HK

Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis

Kim, K; Oh, D; Noh, JM; Min, YW; Kim, HK; Ahn, YC

Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma?

Kim, K; Ahn, YC; Oh, D; Noh, JM; Jeong, HS; Chung, MK; Hong, SD; Baek, CH

Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21-10)

Song, JY; Moon, SH; Suh, YG; Kim, JH; Oh, D; Noh, JM; Jeong, JU; Cho, IJ; Kang, MK; Kim, JH; Kimi, YS; Kimj, HJ; Park, WY; Kim, BH; Kim, HJ

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Kim, H; Park, S; Jung, HA; Lee, SH; Park, K; Ahn, YC; Oh, D; Ahn, MJ

Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors

Choi, N; Kim, HJ; Yi, H; Kim, H; Kim, TH; Jeong, HS; Son, YI; Baek, CH; Oh, D; Ahn, YC; Chung, MK

Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers

So, YK; Kim, Z; Cheong, TY; Chung, MJ; Baek, CH; Son, YI; Seok, J; Jung, YS; Ahn, MJ; Ahn, YC; Oh, D; Cho, BH; Chung, MK

Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial

Lee, M; Kang, D; Kang, E; Kim, S; Kim, Y; Ahn, JS; Park, S; Lee, YY; Oh, D; Noh, JM; Cho, JH

Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma

Lee, YP; Yoon, SE; Cho, J; Ko, YH; Oh, D; Ahn, YC; Kim, WS; Kim, SJ

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

Bae, M; Kim, G; Lee, TR; Ahn, JM; Park, H; Park, SR; Song, KB; Jun, E; Oh, D; Lee, JW; Park, YS; Song, KW; Byeon, JS; Kim, BH; Sohn, JH; Kim, MH; Kim, GM; Chie, EK; Kang, HC; Kong, SY; Woo, SM; Lee, JE; Ryu, JM; Lee, J; Kim, D; Ki, CS; Cho, EH; Choi, JK

Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy

Yun, JM; Chung, MK; Baek, CH; Son, YI; Ahn, MJ; Oh, D; Kim, KW; So, YK

Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer

Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Kim, CG; Yoon, HI; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Shin, EC; Ahn, MJ

Graphical user interface design to improve understanding of the patient-reported outcome symptom response

Lee, MY; Kang, DB; Joi, Y; Yoon, J; Kim, Y; Kim, J; Kang, MW; Oh, D; Shin, SY; Cho, JH

A novel 3D pillar/well array platform using patient-derived head and neck tumor to predict the individual radioresponse

Lee, DW; Choi, SY; Kim, SY; Kim, HJ; Shin, DY; Shim, J; Ku, B; Oh, D; Chung, MK

Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1

Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Yoon, HI; Moon, H; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Ahn, MJ; Shin, EC

Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Park, S; Oh, D; Choi, YL; Chi, SA; Kim, K; Ahn, MJ; Sun, JM

Development and Validation of Digital Health Technology Literacy Assessment Questionnaire

Yoon, J; Lee, M; Ahn, JS; Oh, D; Shin, SY; Chang, YJ; Cho, J

Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study

Park, S; Sun, JM; Choi, YL; Oh, D; Kim, HK; Lee, T; Chi, SA; Lee, SH; Choi, YS; Jung, SH; Ahn, MJ; Ahn, YC; Park, K; Shim, YM

Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer

Yang, K; Suh, YG; Shin, H; Pyo, H; Moon, SH; Ahn, YC; Oh, D; Chung, E; Jo, K; Noh, JM

High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations

Lee, DW; Kim, JE; Lee, GH; Son, A; Park, HC; Oh, D; Jo, K; Choi, C

Increased Risk of Diabetes after Definitive Radiotherapy in Patients with Indolent Gastroduodenal Lymphoma

Baek, JY; Lim, D; Oh, D; Nam, H; Kim, JJ; Lee, JH; Min, BH; Lee, H

Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx

Nam, H; Ahn, YC; Yang, K; Oh, D; Noh, JM

Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors

Kang, D; Kim, Y; Lim, J; Yoon, J; Kim, S; Kang, E; Nam, H; Shim, S; Lee, M; Bok, H; Lee, SW; Shin, SY; Ahn, JS; Oh, D; Cho, J

Oncological and Functional Outcomes of Larynx-Preserving Surgery for Hypopharyngeal Cancer: A Comparison with Definitive Radiation-Based Treatment

Kim, D; Kim, N; Koh, S; Chung, MK; Son, YI; Oh, D; Jeong, HS; Ahn, YC

Tongue Displacement Device in Decreasing the Radiation Dose to Tongue and Preventing Proton Beam Overshoot in Proton Therapy for Unilateral Head and Neck Cancer

Hong, CS; Oh, D; Ju, SG; Ahn, YC; Kim, YB; Park, S; Lee, W

Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment

Lee, M; Kang, D; Kim, S; Lim, J; Yoon, J; Kim, Y; Shim, S; Kang, E; Ahn, JS; Cho, J; Shin, SY; Oh, D

Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study

Yang, K; Oh, D; Noh, JM; Yoon, HG; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Ko, H; Lee, J; Kim, Y

Patient-Reported Outcomes Measurement Information System: Translation and Linguistic Validation of Six Profile Domains for Korean Adults

Kim, Y; Yoon, J; Kim, N; Lee, M; Kang, D; Park, HY; Oh, D; Sung, KS; Suh, GY; Ahn, JS; Cho, J

Trimodality therapy for locally advanced esophageal squamous cell carcinoma: the role of volume-based PET/CT in patient management and prognostication

Choi, Y; Choi, JY; Hong, TH; Choi, YL; Oh, D; Woo, SY; Shim, YM; Zo, JI; Kim, HK; Lee, KS

Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases

Kim¹, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer

Yoon¹, HG; Oh, D; Noh, JM; Cho, WK; Sun, JM; Kim, HK; Zo, JI; Shim, YM; Kim, K

Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients

Yoon¹, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S

Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer

Lim¹, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K

Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients

Yang¹, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM

Development of a Tongue Immobilization Device Using a 3D Printer for Intensity Modulated Radiation Therapy of Nasopharyngeal Cancer Patients

Ju¹, SG; Ahn, YC; Kim, YB; Park, SG; Choi, YM; Na, CH; Hong, CS; Oh, D; Kwon, DY; Kim, CC; Kim, DH

Utility of positron emission-computed tomography for predicting pathological response in resectable oesophageal squamous cell carcinoma after neoadjuvant chemoradiation

Lee¹, J; Choi, JY; Lim, SW; Ahn, MJ; Park, K; Zo, JI; Shim, YM; Oh, D; Sun, JM

The difference in knowledge and attitudes of using mobile health applications between actual user and non-user among adults aged 50 and older

Lee¹, M; Kang, D; Yoon, J; Shim, S; Kim, IR; Oh, D; Shin, SY; Hesse, BW; Cho, J

Effect of photobiomodulation therapy on radiodermatitis in a mouse model an experimental animal study

Park¹, JH; Byun, HJ; Kim, HJ; Oh, SJ; Choi, C; Noh, JM; Oh, D; Lee, JH; Lee, DY

Topical Application of Phlorotannins from Brown Seaweed Mitigates Radiation Dermatitis in a Mouse Model

Yang¹, K; Kim, SY; Park, JH; Ahn, WG; Jung, SH; Oh, D; Park, HC; Choi, C

Feasibility of photobiomodulation therapy for the prevention of radiodermatitis a single-institution pilot study

Park¹, JH; Byun, HJ; Lee, JH; Kim, H; Noh, JM; Kim, CR; Oh, D

Reliability and Validity of the Korean Language Version of the US National Cancer Institute?s Patient -Reported Outcomes Common Terminology Criteria for Adverse Events

Yoon¹, J; Sim, SH; Kang, D; Han, G; Kim, Y; Ahn, J; Oh, D; Lee, ES; Kong, SY; Cho, J; Mitchell, SA

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Yoon¹, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM

The prognostic value of PET/CT evaluation with Deauville score on the recurrence and survival in diffuse large B-cell lymphoma: a multi-institutional study of KROG 17-02

Lee¹, JW; Oh, D; Eom, KY; Kim, JH; Kim, WC; Chung, MJ; Lee, JH

Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review

Lee¹, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH

Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score

Kim¹, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D

A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02)

Chung¹, MJ; Cho, WK; Oh, D; Eom, KY; Kim, JH; Kim, WC; Lee, JH

Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer

Park¹, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S

Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment

Kim¹, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY

Patterns of care for orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross-sectional cohort study (KROG 16-19)

Lee¹, J; Oh, D; Choi, BO; Eom, KY; Lee, JH; Kim, JH; Lee, SW; Suh, YK; Suh, CO

Development of a semi-customized tongue displacement device using a 3D printer for head and neck IMRT

Hong¹, CS; Oh, D; Ju, SG; Ahn, YC; Na, CH; Kwon, DY; Kim, CC

Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma

Park¹, S; Joung, JG; Min, YW; Nam, JY; Ryu, D; Oh, D; Park, WY; Lee, SH; Choi, YL; Ahn, JS; Ahn, MJ; Park, K; Sun, JM

Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma

Lee¹, H; Oh, D; Yang, K; Ko, YH; Ahn, YC; Kim, WS; Kim, SJ

Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients

Cho¹, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC

Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery

Cho¹, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H

Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?

Yoo¹, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH

The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106)

Ha¹, B; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Kim, YS; Wu, HG; Kim, JH; Ahn, YC; Oh, D; Noh, JM; Lee, JH; Kim, SH; Kim, WT; Oh, YT; Kang, MK; Kim, JH; Kim, JY; Cho, MJ; Kay, CS; Choi, JH

Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor

Lee¹, KH; Noh, JM; Ahn, YC; Oh, D; Kim, J; Shim, YM; Han, JH

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion

Kim¹, H; Oh, D; Ahn, YC; Park, K; Ahn, MJ; Lee, SH; Sun, JM; Shim, YM; Zo, JI; Choi, YS; Kim, HK; Cho, JH

Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer

So¹, YK; Lee, G; Oh, D; Byeon, S; Park, W; Chung, MK

Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell

Lee¹, GI; Oh, D; Kim, WS; Kim, SJ; Ko, YH; Woo, KI; Kim, YD; Ahn, YC

Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis

So¹, YK; Oh, D; Choi, N; Baek, CH; Ahn, YC; Chung, MK

Role of radiation therapy in primary central nervous system lymphoma

Koh¹, HK; Kim, IH; Kim, TM; Lim, DH; Oh, D; Cho, JH; Kim, WC; Kim, JH; Chung, WK; Jeong, BK; Kang, KM; Hong, S; Suh, CO; Kim, IA

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer

Sun¹, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K

Normal lung sparing Tomotherapy technique in stage III lung cancer

Hong¹, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience

Park¹, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM

Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07)

Kim¹, Y; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Lee, SW; Ahn, YC; Oh, D; Kim, YS; Won, YK; Wu, HG; Hah, JH; Oh, YT

Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study

Song¹, S; Wu, HG; Lee, CG; Keum, KC; Kim, MS; Ahn, YC; Oh, D; Park, HJ; Lee, SW; Park, G; Moon, SH; Cho, KH; Kim, YS; Won, Y; Oh, YT; Kim, WT; Jeong, JU

A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer

Lee JY¹, Sun JM, Oh D, Lim SH, Chi S, Lee SH, Jung SH, Ahn MJ, Ahn YC, Park K

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery

Cho WK1¹, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.

Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression

Son SM1¹, Ha SY1, Yoo HY2,3, Oh D4, Kim SJ3,5, Kim WS3,5, Ko YH1,3.

Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation

Oh D1¹, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.

Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease?

Kim H1¹, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.

Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

Cho JK1¹, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.

Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules

Cho WK1¹, Noh JM1, Ahn YC1, Oh D1, Pyo H1.

Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma

Noh JM1¹, Lee E1, Ahn YC1, Oh D1, Kim YD2, Woo KI2, Ko YH3, Kim S3.

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma

Oh D1¹, Noh JM, Nam H, Lee H, Kim TG, Ahn YC.

The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis

Song JH1¹, Wu HG2, Keam BS3, Hah JH4, Ahn YC5, Oh D5, Noh JM5, Park HJ5, Lee CG6, Keum KC6, Cha J6, Cho KH7, Moon SH7, Kim JY8, Chung WK9, Oh YT10, Kim WT11, Cho MJ12, Kay CS13, Kim YS14.

Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer

Jang JY1¹, Kim EH2, Cho J2, Jung JH3, Oh D4, Ahn YC4, Son YI2, Jeong HS5.

Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session

Oh D1¹, Huh SJ, Park W, Ju SG, Nam H, Lee JE.

IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06)

Moon SH1¹, Cho KH2, Lee CG3, Keum KC3, Kim YS4, Wu HG5, Kim JH5, Ahn YC6, Oh D6, Lee JH7.

Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial

Yu JI1¹, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.

Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy

Chang JH1¹,2, Ahn YC1, Park H1, Oh D1, Noh JM1, Sun JM3, Ahn MJ3, Park K3.

Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer

Lee H1¹, Ahn YC2, Oh D2, Nam H1, Noh JM2, Park SY2,3.

Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability

Kim SM1¹, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.

Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02)

Lee JY1¹, Sun JM1, Oh DR2, Lim SH1, Goo J3, Lee SH1, Kim SB4, Park KU5, Kim HK6, Hong DS7, Kim JS8, Kim SG9, Yi SY10, Yun HJ11, Hyun MS12, Kim HJ13, Jung SH3, Park K1, Ahn YC14, Ahn MJ15.

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Lim SH1¹, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.

Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer

Hong CS1¹, Oh D1, Ju SG1, Ahn YC1, Noh JM1, Chung K1, Kim JS1, Suh TS2.

Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

Noh JM1¹, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.

Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Oh D1¹, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.

Role of Chemotherapy in Stacie II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy

Kang MK1¹, Oh D2, Cho KH3, Moon SH3, Wu HG4, Heo DS5, Ahn YC2, Park K6, Park HJ2, Park JS2, Keum KC7, Cha J7, Kim JW7, Kim YS8, Kang JH9, Oh YT10, Kim JY11, Kim SH12, Kim JH13, Lee CG7.

Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type

Cho HJ1¹, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer

Noh JM1¹, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.

Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck

Noh JM1¹,?Ha SY2,?Ahn YC1,?Oh D1,?Seol SW1,?Oh YL2,?Han J2.

Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients

Cho JK1¹, Lee GJ2, Yi KI3, Cho KS3, Choi N2, Kim JS2, Kim H4, Oh D4, Choi SK5, Jung SH5, Jeong HS2, Ahn YC6.

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy

Oh D1¹, Shin SW2, Park HC1, Cho SK2, Lim do H1, Paik SW3.

Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy

Lee H1¹, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.

Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer

Lee H1¹, Ahn YC, Oh D, Nam H, Kim YI, Park SY.

Prognostic Significance of Tumor Response as Assessed by Sequential F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography During Concurrent Chemoradiation Therapy for Cervical Cancer

Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma

Yoon H1¹, Oh D, Park HC, Kang SW, Han Y, Lim DH, Paik SW.

Hypofractionated Three-Dimensional Conformal Radiation Therapy Alone for Centrally Located cT1-3N0 Non-Small-Cell Lung Cancer

Oh D1¹, Ahn YC, Kim B, Pyo H.

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor

Oh D1¹, Ahn YC, Kim K, Kim J, Shim YM, Han J.